Coronavirus Update: India Grants Emergency Approval To J&J Vaccine
Korea Looks To Tighten Vaccine Handling
India has issued an emergency authorization to J&J's single-dose COVID-19 vaccine, while a South Korean report calls for improved vaccine handling standards amid lapses and losses.
You may also be interested in...
Zydus Cadila Turns DNA Pioneer With COVID-19 Vaccine Approval
With an emergency approval, Zydus Cadila has commercialized the world’s first plasmid DNA vaccine for human use and the first COVID-19 vaccine for use in adolescents in India. Will efficacy against the Delta variant help tide over hesitancy towards a new technology or a lack of publicly published data hamper acceptance?
Can Delta Variant Effectiveness Fill Brazil-Sized Hole In Bharat Biotech’s Prospects?
A study indicates that the Delta variant of SARS-CoV-2 and its sub-lineage Delta Plus can be neutralized by Bharat Biotech’s COVID-19 vaccine, but a federal investigation in Brazil and a class action suit against its US partner have hurt the firm’s global ambitions. Experts weigh in on what the future could possibly hold.
COVID-19 Vaccine Safety Now: Soft Rollout, Not Pause, After Reports Of Guillain-Barré Syndrome
Unlike its response to incidents of blood clots with J&J’s vaccine, the US FDA is not calling for a pause in its administration following reports of about 100 cases of Guillain-Barré syndrome. CDC advisory panel is to discuss the issue at an upcoming meeting.